Ricardo Dolmetsch, PhD
Ricardo Dolmetsch is global head of neuroscience at the Novartis Institutes for BioMedical Research. His group is responsible for developing medicines to treat neuropsychiatric, neurodevelopmental, and neurodegenerative diseases. It focuses on targets and mechanisms that have been validated in humans , either by human genetic studies or by astute clinical observations. Dolmetsch joined Novartis from Stanford University, where he was a professor and continues to be an adjunct professor at Stanford Medical School. He was also a senior director at the Allen Institute for Brain Science, where his group studied the molecular basis of autism and other neurodevelopmental disorders. He received his undergraduate degree from Brown University and his graduate degree from Stanford University, and was a postdoctoral fellow at Harvard University.